J. Bao

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

Honggang Zhou, Jianping Lin, Dongmei Li, 2021, Phytomedicine.

Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice

Honggang Zhou, Jianping Lin, Dongmei Li, 2021, Inflammation.

Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1

Honggang Zhou, Zhun Bi, Cheng Yang, 2022, Phytotherapy research : PTR.

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation

Honggang Zhou, Jianping Lin, Dongmei Li, 2021, Frontiers in Pharmacology.

Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT.

Honggang Zhou, Chun-feng Xie, Cheng Yang, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway

Honggang Zhou, Cheng Yang, Yuemei Gao, 2023, International journal of molecular sciences.

Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma.

Honggang Zhou, Zihui Zhang, Chunya Lu, 2023, Pulmonary pharmacology & therapeutics.

Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo study.

Cheng Yang, Honggang Zhou, Guang Yang, 2023, European journal of pharmacology.

特发性肺纤维化合并非小细胞肺癌的致病机制及潜在治疗药物研究进展

Ting Xiao, Xiangning Liu, J. Bao, 2022, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

An Analysis of the Anti-Neuropathic Effects of Qi She Pill Based on Network Pharmacology

Gan Li, Yong-jun Wang, Yong-jia Song, 2020, Evidence-based complementary and alternative medicine : eCAM.